IV thrombolysis given within 4.5 hours of acute pontine infarction may significantly reduce neurological deterioration vs ...

A prehospital blood test may rapidly distinguish between ischemic and hemorrhagic strokes, potentially enabling more timely, ...

In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.

MIND was a prospective, open-label trial that enrolled adults up to 80 years old with moderate-large (20-80 mL) ...

Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...

Portable point-of-care blood tests, done by EMS before hospital arrival, need validation but could guide treatment and ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Accurate diagnosis of transient ischemic attacks (TIAs) is challenging. This study was aimed at analyzing ...

Introduction: The use of IV thrombolysis (IVT) in acute ischemic stroke patients presenting with an NIHSS of ≤ 5 has failed to demonstrate benefit, particularly when the symptoms are considered ...

Background: We investigate whether the NIHSS at 24 hours could serve as an alternative primary outcome measure in acute ischemic stroke trials, and whether combining 90-day modified Rankin Score (mRS) ...

Furthermore, the top 5 variables suggesting unfavorable outcomes were namely admitting blood glucose levels, age, onset to EVT time, onset to hospital time, and National Institutes of Health Stroke ...